Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung
- Conditions
- AsthmaChronic Obstructive Pulmonary DiseaseInterstitial Lung DiseasesOccupational Lung Diseases
- Registration Number
- NCT00511290
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.
The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
- Ages 7-80
- FEV1 < 75% predicted pO2 < 75
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Tel-Aviv Sourasky Medical Center
🇮🇱Tel-Aviv, Israel
Tel-Aviv Sourasky Medical Center🇮🇱Tel-Aviv, Israel